- Circ.Res. 101(3):268-276 (2007)
- Nat.Rev.Cancer 7(5):332-344 (2007)
- Genes Dev. 20(24):3347-3365 (2006)
- J.Thromb.Haemost. 4(3):671-677 (2006)
- J Clin Oncol 26(11):1810-1816 (2008)
- Br.J.Cancer 101(10):1717-1723 (2009)
- J.Clin.Oncol. 26(32):5204-5212 (2008)
- The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathwayCurr.Clin.Pharmacol. 3(2):132-143 (2008)
- J.Leukoc.Biol. 64(2):135-146 (1998)
- Blood 103(9):3603-3605 (2004)
- Genes Dev. 16(7):773-783 (2002)
- Clin.Sci.Lond 100(5):567-575 (2001)


user